Genfit S.A. (GNFTF)
OTCMKTS
· Delayed Price · Currency is USD
3.540
+0.100 (2.91%)
At close: Dec 27, 2024
Genfit Revenue
In the year 2024, Genfit had annual revenue of 70.94M EUR with 105.72% growth. Genfit had revenue of 61.10M in the half year ending June 30, 2024, with 403.23% growth.
Revenue
70.94M EUR
Revenue Growth
+105.72%
P/S Ratio
2.12
Revenue / Employee
446.16K EUR
Employees
159
Market Cap
182.54M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 70.94M | 36.46M | 105.72% |
Dec 31, 2023 | 34.48M | 8.24M | 31.38% |
Dec 31, 2022 | 26.25M | -59.11M | -69.25% |
Dec 31, 2021 | 85.36M | 76.67M | 883.14% |
Dec 31, 2020 | 8.68M | -30.29M | -77.72% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Genfit News
- 14 days ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
- 5 weeks ago - GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders - GlobeNewsWire
- 6 weeks ago - Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs - GlobeNewsWire
- 2 months ago - GENFIT Announces Revenues and Cash Position as of December 31, 2024 - GlobeNewsWire
- 2 months ago - Genfit reports preliminary results of repurchase offer to 2025 OCEANEs holders - Seeking Alpha
- 2 months ago - GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders' general meeting - GlobeNewsWire
- 2 months ago - GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders - GlobeNewsWire
- 2 months ago - GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025 - GlobeNewsWire